期刊文献+

雌激素受体拮抗剂对垂体腺瘤GH3细胞增殖、凋亡、催乳素分泌及雌激素受体蛋白表达的影响 被引量:3

Differential effects of estrogen receptor antagonists on pituitary GH3 cell proliferation, apoptosis, PRL secretion, and ER protein expression
原文传递
导出
摘要 目的通过检测雌激素受体拮抗剂对垂体腺瘤GH3细胞增殖、凋亡、催乳素(PRL)分泌及雌激素受体蛋白表达的影响,探讨雌激素在垂体催乳素腺瘤发生、发展中的作用机制。方法对去激素培养条件及加入外源性E2培养条件下的GH3细胞采用不同方法进行检测:应用MTT法检测OHTam与ICI对GH3细胞增殖的影响;ELISA法检测对GH3细胞PRL分泌的影响;流式细胞仪测定细胞凋亡率;Westernblot检测对GH3细胞ERd、ERB表达的影响。结果E2对GH3细胞增殖有显著的生长刺激作用,低浓度E2(10^-12mol/L)即显著高于去激素培养组;OHTam与ICI对GH3细胞增殖有抑制作用,当给药浓度达到10^-6mol/L时,增殖指数分别为0.62和0.47,呈剂量依赖性;OHTam与ICI可抑制E2对GH3细胞的生长刺激作用;以上结果与对照组相比差异有统计学意义(P〈0.05)。E2可促进GH3细胞的PRL的分泌,随着E2浓度的增高,PRL的分泌增加;OHTam与ICI可抑制GH3细胞PRL的分泌,并且能够抑制E2的促进作用。OHTam与ICI能够诱导GH3细胞凋亡,以早期凋亡为主。GH3细胞有ER仪与ERβ的表达,E2可上调ERp的表达水平,ICI可下调ER仅的表达水平,而OHTam对ER仪与ERB的表达水平无显著影响。结论雌激素受体拮抗剂是通过抑制细胞增殖、PRL分泌及抗雌激素而发挥抑瘤作用,而ICI的作用还与下调ERα的表达有关。 Objective To detect the effects of estrogen receptor antagonists on pituitary GH3 cell proliferation, apoptosis, prolactin (PRL) secretion, and estrogen receptor ( ER ) isoforms expressions, and to investigate the mechanisms of exogenous estrogen( 17β- estradiol, E2) in prolactinoma tumorigenesis and development. Method Different methods had been used to test the GH3 ceils cultured with hormone - deprived&phenol red - free medium or exogenous E2 - added medium : MTF assays were used to detect the inhibitory effects of OHTam and ICI on proliferation of GH3 cells;rat PRL ELISA kit was applied to the detection of PRL secretion ; flow cytometry was used to detect OHTam and ICI induced cell apoptosis ; Western blot analysis was applied to the detection of ERct and ERβ expressed in GH3 cells. Results E2 had significant stimulatory effect on growth of GH3 cells, and the effect worked even at low concentration of 10^- 12 mol/L compared to the hormone- deprived medium cultured GH3 cells. OHTam and ICI could inhibit GH3 cell proliferation as dose -dependent manner, when the concentration rising to 10-6 mol/L, the cell proliferation index were 0. 62 and 0. 47 respectively;OHTam and ICI could suppressed the stimulatory effect of E2 on GH3 cell proliferation. All the results had statistical significance ( P 〈 0. 05 ). E2 could increase PRL secretion in GH3 cells and the effect appeared to be dose -dependent;OHTam and ICI decreased PRLsecretion, and could inhibit the promotion effect of E2. OHTam and ICI could induced GH3 cells apoptosis, mostly early apoptosis. The expression of ERα and ERβ in GH3 cells were observed, E2 up - regulated ER~ expression level, and ICI obviously down- regulated the expression of ERα, however, OHTam couldn't regulate the expression levels of ERα and ERβ. Conclusion Estrogen receptor antagonists can inhibit GH3 cell proliferation and PRL secretion, induce cell apoptosis, and inhibit the effect of E2, and thus, generate antitumor effects. In addition, ICI can down - regulate the expression of ERα, and that may be related to its antitumor effects.
出处 《中华神经外科杂志》 CSCD 北大核心 2012年第3期285-290,共6页 Chinese Journal of Neurosurgery
基金 基金项目:国家自然科学基金青年科学基金项目(30801176) 吉林省自然科学基金面上项目(201115096)
关键词 催乳素腺瘤 雌激素类 催乳素 受体 雌激素 雌激素受体拮抗剂 Prolactinoma Estrogens Prolactin Receptor, estrogen Estrogen receptor antagonist
  • 相关文献

参考文献20

  • 1初明,胡志强,魏兰兰,刘爽,张树卓,刘恩重.白黎芦醇对垂体腺瘤GH3细胞生长及其分子机制的研究[J].中华医学杂志,2003,83(22):2004-2006. 被引量:10
  • 2Heaney AP,Femando M,Melmed S. Functional role of estrogen in pituitary tumor pathogenesis[J].Journal of Clinical Investigation,2002.277-283.
  • 3Molitch ME. Medical management of prolactin-secreting pituitary adenomas[J].Pituitary,2002,(2):55.doi:10.1023/A:1022375429083.
  • 4Kansra S,Yamagata S,Ben-Jonathan N. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release[J].Molecular and Cellular Endocrinology,2005.27-36.
  • 5Lee SY,Ahn BT,Baik SH. Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis[J].Neurosurgery,1998.116-123.
  • 6Spady TJ,McComb RD,Shull JD. Estrogen action in the regulation of cell proliferation,cell survival,and tumorigenesis in the rat anterior pituitary gland[J].Endocrinology,1999.217.
  • 7Xu RK,Wu XM,Di AK. Pituitary prolactin-secreting tumor formation:recent developments[J].Biological Signals and Receptors,2000.1.
  • 8Elias KA,Weiner RI. Direct arterial vascularization of estrogeninduced prolactin-secreting anterior pituitary tumors[J].Proceedings of the National Academy of Sciences(USA),1984.4549-4533.
  • 9吴雪梅,张荣,许荣焜,周远征,狄安稞,单惠敏,黄曼影,王悦.异体垂体移植大鼠E_2诱致催乳素瘤的实验研究[J].中国医学科学院学报,1998,20(4):257-263. 被引量:6
  • 10佟晓光,杨树源,张建宁.垂体泌乳素腺瘤中ER基因表达与肿瘤增殖活性的关系[J].中国临床神经外科杂志,2001,6(2):90-92. 被引量:9

二级参考文献21

  • 1[1]Lewis S,Blevins,Denise K et al . Aggressive pituitary tumors. Oncology,1998,21(9): 1307
  • 2[2]Allyn Bregman. Laboratory investigations in cell & mol-ecular biology. Third Edition. Canada: John Wiley & Sons Inc. 1990. 116
  • 3[3]Hsu DW,Hakim F,Biller BMK et al . Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg,1993,78 753
  • 4[4]Murphy FY,Vesely DL,Jordan RM et al . Giant inva-sive prolactinomas. Am J Med,1987,83:995
  • 5[5]Kauppila A. Oestrogen and progestin receptors as prog-nostic indicators in endometrial cancer. Acta Oncologica,1989,28:561
  • 6[6]Stefaneanu L,Kovacs K,Horvath E et al . In situ hy-bridization study of estrogen receptor messenger ribonu-cleic acid in human adenohypophysial cells and pitui-tary adenomas. J Clin Endocrinol Metab,1994,78:83
  • 7[7]Kovacs L,Stefaneanu L,Horvath E et al . Prolactin-producing pituitary tumor:resistance to dopamine agonisttherapy. J Neurosurg,1995,82:886
  • 8谢启文,神经内分泌学,1990年,61页
  • 9Xu R K,Life Sci,1989年,145卷,1591页
  • 10夏朴,国外医学.内分泌学分册,1989年,1卷,1页

共引文献22

同被引文献51

  • 1袁瑞,乐爱文,耿力,卞度宏,姚珍薇.雌激素受体α基因多态性与原因不明月经过少的相关性研究[J].中国医科大学学报,2007,36(4):382-384. 被引量:3
  • 2乐爱文,袁瑞,姚珍薇,朱元方,耿力.原因不明月经过少雌激素受体α基因多态性及其表达的研究[J].生殖与避孕,2007,27(10):648-652. 被引量:4
  • 3Dang VH, Nguyen TH, Choi KC, et al. A calcium-binding pro- tein, Calbindin-D9k, is regulated through an estrogen-receptor- mediated mechanism following xenoestrogen exposure in the GH3 cell line[J]. Toxicol Sei,2007,98(2) :408-415.
  • 4Hong E J, Ji YK, Choi KC, et al. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k [ J ]. J Repmd Dev, 2005,51 ( 2 ) : 253 -263.
  • 5Jung EM, An BS, Yang H, et al. Biomarker genes for detecting estrogenic activity of endocrine disrupts via estrogen receptors [ J ]. Int J Environ Res Public Health ,2012,9 (3) :698-711.
  • 6Vo TT, Jeung EB. An evaluation of estrogenic activity of parabens using uterine calbindin-D9k gene in an immature rat model[ J]. Toxicol Sci,2009,112( 1 ) :68-77.
  • 7Lee GS, Kim HJ, Jung YW, et al. Estrogen receptor alpha path- way is involved in the regulation of Calbindin-D9k in the uterus of immature rats [ J ]. Toxicol Sci,2005,84 ( 2 ) :270-277.
  • 8Kansra S, Yamagata S, Sneade L, et al. Differential effects of es- trogen receptor antagonists on pituitary lactotroph proliferation and prolaetin release [ J ]. Mol Cell Endocrinol, 2005,239 ( 1-2 ) : 27 -36.
  • 9Yoo YM, Jeung EB. Melatonin-induced estrogen receptor alpha- mediated calbindin-D9k expression plays a role in H202-mediated cell death in rat pituitary GH3 cells [ J ]. J Pineal Res, 2009,47 (4) :301-307.
  • 10Kim SM, Jung EM, An BS, et al. Additional effects of bisphenol A and paraben on the induction of calbindin-D9k and progesterone receptor via an estrogen receptor pathway in rat pituitary GH3 cells [ J]. J Physiol Pharmacol,2012,63(5 ) :445-455.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部